Detection of sFas, sCD137, and IL-27 Cytokines as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis

References

• Rumgay H, Arnold M, Ferlay J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598–1606. doi:10.1016/j.jhep.2022.08.021
   PubMed Web of Science ®Google Scholar
• Llovet J, Kelley R, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6. doi:10.1038/s41572-020-00240-3
   PubMed Web of Science ®Google Scholar
• Wang W, Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes Dis. 2020;7(3):308–319. doi:10.1016/j.gendis.2020.01.014
   PubMed Web of Science ®Google Scholar
• Sarveazad A, Agah S, Babahajian A, Amini N, Bahardoust M. Predictors of 5 year survival rate in hepatocellular carcinoma patients. J Res Med Sci. 2019;24:86. doi:10.4103/jrms.JRMS_1017_18
   PubMed Web of Science ®Google Scholar
• Tsuchiya N, Sawada Y, Endo I, Saito K, Uemura Y, Nakatsura T. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol. 2015;21(37):10573–10583. doi:10.3748/wjg.v21.i37.10573
   PubMed Web of Science ®Google Scholar
• Adeniji N, Dhanasekaran R. Current and Emerging Tools for Hepatocellular Carcinoma Surveillance. Hepatol Commun. 2021;5(12):1972–1986. doi:10.1002/hep4.1823
   PubMed Web of Science ®Google Scholar
• Kim SY, An J, Lim Y-S, et al. MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma. JAMA Oncol. 2017;3(4):456–463. doi:10.1001/jamaoncol.2016.3147
   PubMed Web of Science ®Google Scholar
• Liang Y, Xu F, Guo Y, et al. Diagnostic performance of LI-RADS for MRI and CT detection of HCC: a systematic review and diagnostic meta-analysis. Eur J Radiol. 2021;134:109404. doi:10.1016/j.ejrad.2020.109404
   PubMed Web of Science ®Google Scholar
• Best J, Bilgi H, Heider D, et al. The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma. Z Gastroenterol. 2016;54(12):1296–1305. doi:10.1055/s-0042-119529
   PubMed Web of Science ®Google Scholar
• Yang JD, Addissie BD, Mara KC, et al. GALAD score for hepatocellular carcinoma detection in comparison with liver ultrasound and proposal of GALADUS score. Cancer Epidemiol Biomarkers Prev. 2019;28(3):531–538. doi:10.1158/1055-9965.EPI-18-0281
   PubMed Web of Science ®Google Scholar
• Pan Y, Chen H, Yu J. Biomarkers in hepatocellular carcinoma: current status and future perspectives. Biomedicines. 2020;8(12):576. doi:10.3390/biomedicines8120576
   PubMed Web of Science ®Google Scholar
• Cesati M, Scatozza F, D’arcangelo D, et al. Investigating serum and tissue expression identified a cytokine/chemokine signature as a highly effective melanoma marker. Cancers. 2020;12(12):3680. doi:10.3390/cancers12123680
   PubMed Web of Science ®Google Scholar
• Kartikasari AER, Huertas CS, Mitchell A, Plebanski M. Tumor-induced inflammatory cytokines and the emerging diagnostic devices for cancer detection and prognosis. Front Oncol. 2021;11:692142. doi:10.3389/fonc.2021.692142
   PubMed Web of Science ®Google Scholar
• Esquivel-Velazquez M, Ostoa-Saloma P, Palacios-Arreola MI, Nava-Castro KE, Castro JI, Morales-Montor J. The role of cytokines in breast cancer development and progression. J Interferon Cytokine Res. 2015;35(1):1–16. doi:10.1089/jir.2014.0026
   PubMed Web of Science ®Google Scholar
• Yuan J-M, Wang Y, Wang R, et al. Serum IL27 in relation to risk of hepatocellular carcinoma in two nested case–control studiesIL27 and HCC. Cancer Epidemiol Biomarkers Prev. 2021;30(2):388–395. doi:10.1158/1055-9965.EPI-20-1081
   PubMed Web of Science ®Google Scholar
• Li H, Wang Y, Zhang M, Hu J, Li Z, Han BJ. The high expression of TNF-α and NF-κB in tumor microenvironment predicts good prognosis of patients with BCLC-0-B hepatocellular carcinoma. Transl Cancer Res. 2019;8(2):532. doi:10.21037/tcr.2019.03.09
   PubMed Web of Science ®Google Scholar
• Adachi Y, Nojima M, Mori M, et al. Serum soluble fas levels and incidence of liver cancer in nested case–control study. Cancer Epidemiol Biomarkers Prev. 2023:OF1–OF6. doi:10.1158/1055-9965.EPI-22-0902
   Web of Science ®Google Scholar
• Sadeghi M, Lahdou I, Oweira H, et al. Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma. Br J Cancer. 2015;113(5):756–762. doi:10.1038/bjc.2015.227
   PubMed Web of Science ®Google Scholar
• Weigand K, Peschel G, Grimm J, et al. Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol‐associated disease etiology. Eur J Immunol. 2022;52(4):633–645. doi:10.1002/eji.202149488
   PubMed Web of Science ®Google Scholar
• Rousalova I, Krepela E. Granzyme B-induced apoptosis in cancer cells and its regulation (review). Int J Oncol. 2010;37(6):1361–1378. doi:10.3892/ijo_00000788
   PubMed Web of Science ®Google Scholar
• Akoglu H. User’s guide to sample size estimation in diagnostic accuracy studies. Turk J Emerg Med. 2022;22(4):177–185. doi:10.4103/2452-2473.357348
   PubMed Web of Science ®Google Scholar
• Le VQ, Nguyen VH, Nguyen VH, et al. Epidemiological characteristics of advanced hepatocellular carcinoma in the northern region of Vietnam. Cancer Control. 2019;26(1):1073274819862793. doi:10.1177/1073274819862793
   Web of Science ®Google Scholar
• Hardy-Werbin M, Rocha P, Arpi O, et al. Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer. Oncoimmunology. 2019;8(6):e1593810. doi:10.1080/2162402X.2019.1593810
   PubMed Web of Science ®Google Scholar
• Verbakel JY, Steyerberg EW, Uno H, et al. ROC curves for clinical prediction models part 1. ROC plots showed no added value above the AUC when evaluating the performance of clinical prediction models. Comp Stud. 2020;126:207–216. doi:10.1016/j.jclinepi.2020.01.028
   Google Scholar
• Fernandez-Felix B, García-Esquinas E, Muriel A, Royuela A, Zamora JJ. Bootstrap internal validation command for predictive logistic regression models. Stata J. 2021;21(2):498–509. doi:10.1177/1536867X211025836
   Web of Science ®Google Scholar
• Tomas I, Arias-Bujanda N, Alonso-Sampedro M, et al. Cytokine-based predictive models to estimate the probability of chronic periodontitis: development of diagnostic nomograms. Sci Rep. 2017;7(1):11580. doi:10.1038/s41598-017-06674-2
   PubMedGoogle Scholar
• Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.9791
   PubMed Web of Science ®Google Scholar
• Lien MY, Tsai HC, Chang AC, et al. Chemokine CCL4 induces vascular endothelial growth factor C expression and lymphangiogenesis by miR-195-3p in oral squamous cell carcinoma. Front Immunol. 2018;9:412. doi:10.3389/fimmu.2018.00412
   PubMed Web of Science ®Google Scholar
• Ueno T, Toi M, Tominaga T. Circulating soluble Fas concentration in breast cancer patients. Clin Cancer Res. 1999;5(11):3529–3533.
   PubMed Web of Science ®Google Scholar
• Vysotskii MM, Digaeva MA, Kushlinskii NE, et al. Serum sFas, leptin, and VEGF in patients with ovarian cancer and benign tumors. Bull Exp Biol Med. 2009;148(5):810–814. doi:10.1007/s10517-010-0823-5
   PubMed Web of Science ®Google Scholar
• Sheen-Chen SM, Chen HS, Eng HL, Chen WJ. Circulating soluble Fas in patients with breast cancer. World J Surg. 2003;27(1):10–13. doi:10.1007/s00268-002-6378-5
   PubMed Web of Science ®Google Scholar
• Bartkowiak T, Jaiswal AR, Ager CR, et al. Activation of 4-1BB on liver myeloid cells triggers hepatitis via an interleukin-27–dependent pathway. Clin Cancer Res. 2018;24(5):1138–1151. doi:10.1158/1078-0432.CCR-17-1847
   PubMed Web of Science ®Google Scholar
• Glez-Vaz J, Azpilikueta A, Olivera I, et al. Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies. J Immunother Cancer. 2022;82(12_Supplement):628. doi:10.1136/jitc-2021-003532
   Google Scholar
• Labiano S, Palazón A, Bolanos E, et al. Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism. Oncoimmunology. 2016;5(1):e1062967. doi:10.1080/2162402X.2015.1062967
   PubMed Web of Science ®Google Scholar
• Fabbi M, Carbotti G, Ferrini S. Dual Roles of IL-27 in Cancer Biology and Immunotherapy. Mediators Inflamm. 2017;2017:3958069. doi:10.1155/2017/3958069
   PubMed Web of Science ®Google Scholar
• Song Q, Zhu X, Jin L, Chen M, Zhang W, Su J. SMGR: a joint statistical method for integrative analysis of single-cell multi-omics data. NAR Genom Bioinform. 2022;4(3):lqac056. doi:10.1093/nargab/lqac056
   PubMedGoogle Scholar
• Zhu J, Tang B, Gao Y, et al. Predictive models for HCC prognosis, recurrence risk, and immune infiltration based on two exosomal genes: MYL6B and THOC2. J Inflamm Res. 2021;14:4089–4109. doi:10.2147/JIR.S315957
   PubMed Web of Science ®Google Scholar
• Liu R, Wang G, Zhang C, Bai D. A prognostic model for hepatocellular carcinoma based on apoptosis-related genes. World J Surg Oncol. 2021;19(1):70. doi:10.1186/s12957-021-02175-9
   PubMed Web of Science ®Google Scholar
• Sato M, Morimoto K, Kajihara S, et al. Machine-learning approach for the development of a novel predictive model for the diagnosis of hepatocellular carcinoma. Sci Rep. 2019;9(1):7704. doi:10.1038/s41598-019-44022-8
   PubMedGoogle Scholar